- Shingles (herpes zoster)
WHO fact sheet on shingles (herpes zoster), including key facts, risk factors, symptoms, transmission, diagnosis, treatment and WHO response
- Post COVID-19 condition (long COVID)
These symptoms might persist from their initial illness or develop after their recovery Symptoms can be mild to severely debilitating, and affect someone’s capacity to work, perform their daily activities or do exercise With increasing understanding of post COVID-19 condition, some clinical patterns have become clearer
- Candidiasis (yeast infection)
WHO fact sheet on candidiasis, including key facts, yeast infections, oral thrush, invasive candidiasis, causes, symptoms, treatment, prevention and WHO response
- Coronavirus disease (COVID-19)
WHO fact sheet on coronavirus disease (COVID-19), including symptoms, treatment, prevention and WHO's response
- Coronavirus - World Health Organization (WHO)
Coronavirus disease (COVID-19)The virus can spread from an infected person’s mouth or nose in small liquid particles when they cough, sneeze, speak, sing or breathe These particles range from larger respiratory droplets to smaller aerosols It is important to practice respiratory etiquette, for example by coughing into a flexed elbow, and to stay home and self-isolate until you recover if
- Influenza - World Health Organization (WHO)
Symptoms Influenza is characterized by a sudden onset of high fever, cough, headache, muscle and joint pain, malaise, and a runny nose lasting 2 to 7 days Influenza is usually mild and uncomplicated and most people recover without medical treatment
- Human metapneumovirus (hMPV) infection
Human metapneumovirus usually causes cold or flu-like symptoms However, how sick a person gets depends on many things, including their overall health Also, since viruses can evolve, their severity may change WHO works with global experts to monitor these changes
- COVID-19 - Global Situation - World Health Organization (WHO)
Since mid-February 2025, according to data available from sentinel sites, global SARS-CoV-2 activity has been increasing, with the test positivity rate reaching 11%, levels that have not been observed since July 2024 This rise is primarily observed in countries in the Eastern Mediterranean, South-East Asia, and Western Pacific regions Since early 2025, global SARS-CoV-2 variant trends have
|